IRBM, an integrated Contract Research Organization (CRO) specializing in preclinical drug discovery, has established a ...

Researchers designed a CRISPR-based test that rapidly detects low levels ... It also detected multi-drug-resistant Staphylococcus aureus DNA without prior amplification at concentrations that ...

highly sensitive detection of multi-drug-resistant bacteria and other pathogens at low concentrations. Researchers designed a CRISPR-based test that rapidly detects low levels of pathogen genetic ...

The lab will offer arrayed CRISPR screening for chronic disease through collaborations with researchers from across the U.K.

The company recently announced the start of patient screening for a phase ... rather than systemic dosing of the CRISPR agent. Takeda's Adcetris has become the first drug recommended for routine ...

CRISPR gene editing technology has been heralded as a revolutionary breakthrough in drug development, enabling scientists to potentially cure genetic diseases by modifying the genes that cause them.

The startup is using CRISPR tools to stop errant expression of a gene linked to facioscapulohumeral muscular dystrophy, a ...

The FDA has lost no time in approving Vertex Pharma and CRISPR Therapeutics pioneering gene-editing therapy Casgevy for its second use, approving the drug for transfusion-dependent beta ...

Tulane University researchers have developed a CRISPR-based test that diagnoses Pneumocystis jirovecii pneumonia (PJP) - a life-threatening fungal infection primarily affecting children and ...

“Using our nano-lipid delivery system, we injected the drug directly into the tumor in a tumor model and successfully took out the gene – literally cutting it out from the cancer cell’s DNA with the ...